Nordic Life Science 1
TOP STORIES BUSINESS Linn Wrangmark and Frida McC
abe BUSINESS Anders Kronborg, acting CEO, LEO Pharma Rune Nystad, CEO, Biim Ultrasound and Björn Larsson, CEO, Observe Medical . developed a wireless and pocketable ultrasound probe that can scan patients and review images in seconds. Biim’s technology is patented, and the device received 510 (k) clearance from the US Food and Drug Administration in 2018. A partner agreement with Fresenius Kidney Care is already in place, whereby Biim is intended to be used across Fresenius’ dialysis centers in the US.The companies had combined pro forma revenues of NOK 25 million in 2020 and have offices in Norway, Sweden, Finland and the US. Biim Ultrasound’s US network is also expected to further drive the pace of the global commercial roll-out of Sippi, Observe Medical’s automated digital urine meter with biofilm control and wireless connectivity, accelerating the current roll-out in Europe and driving an earlier US market entry. The agreement is expected to be completed in March 2022. unveiled its strategy towards 2030. The first phase of this process – including the introduction of a new capital and governance structure – was recently completed. Following the new strategy, the global R&D organization will now focus the in-house drug discovery on promising small molecule technologies and further increasing productivity to realize the company’s ambition to launch a new innovative asset or enter a new indication every two to three years. Other initiatives include driving efficiencies through outsourcing, further standardization, boosting digitalization as well as centralizing systems, data and analytics. Also, the Open Innovation, Regenerative Medicine and the Science & Tech Hubs in Asia and US, will be closed. The changes are expected to affect around 1,000 positions in the global organization over the next two years. 18 NORDICLIFESCIENCE.ORG PHOTO BÅRD GUDIM